DF/HCC "Pipelines in Oncology" Seminar - TetraLogic Pharmaceuticals
Date: February 21, 2013 12:30 PM - 02:00 PM
Location: Dana Farber Cancer Institute, 450 Brookline Ave, Yawkey 306
Contact: richard_power@dfci.harvard.edu
Documents:
Description:
Back
TetraLogic Senior Scientists will present on Birinapant, their lead Smac mimetic drug. We will hear from:
David Weng, MD, PhD, Senior Vice President and Chief Medical Officer
Martin Graham, PhD, VP of Development
Stephen M. Condon, PhD, VP of Chemistry
Srinivas Chunduru, PhD, Sr. Director of Biology